medical hospital

Сообщения

Trending with Impact: Exacta® Guides Treatment and Identifies HER2

января 28, 2021

In a case presentation paper, Encyclopedic Tumor Analysis guided researchers in identifying HER2 overexpression in a patient with distal common bile duct carcinoma and in personalizing his treatment regimen. oncotarget research Microscopic ductal cell carcinoma. Adenonocarcinoma from human breast cancer tissue. Magnification 400X Microscopic ductal cell carcinoma. Adenonocarcinoma from human breast cancer tissue. Magnification 400X The Trending with Impact series highlights publications attracting higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news and articles about the latest trending publications here and at Oncotarget.com. oncotarget journal impact factor Researchers from multiple highly-regarded institutions located in India and from the Medical College of Wisconsin in the United states wrote a paper on the case presentation: “Liquid biopsy and multi-analyte testing guided trea

Далее...

clinics in us

января 27, 2021

When public refer to modern medicine, precision plays one of the most important roles and people’s lives are literally dependent on it. Likewise, any researches pertaining to medicine are required to comply with the highest standards. The issue nowadays is that any results of researches can be posted online and used as a reference without being properly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and decided to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The key principle of this journal is based on Altmetric scores that are used as a quality indicator. That allows both readers and authors to quality-check publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a complete publications list with respective scores higher than 10

Далее...

MEK Inhibitors Show Promising Potential in Pseudo COVID-19 Study

января 26, 2021

A promising new treatment option for the coronavirus was studied using a COVID-19 pseudovirus approach to observe its immune response to MEK inhibitors. Hospital As researchers around the world are in the midst of searching for treatment options capable of combatting the COVID-19 virus, a single solution will not be effective for everyone—in both a logistical and biological sense. To produce different treatment options for populations of varying age and immune system health, numerous avenues are currently being explored. Oncotarget One potential treatment, studied by a coalition of researchers from Brown University, the Fox Chase Cancer Center, and Verastem Oncology, used a COVID-19 pseudovirus approach to demonstrate immune response to MEK inhibitors in a level 2 biosafe environment. The paper detailing this study has been published at Oncotarget.com. “For the current study, we have developed a pseudotyped SARS-CoV-2 virus which has a lentiviral core but with the SARS-CoV-2 spik

Далее...

us clinics lists

января 26, 2021

When people discuss contemporary medicine, precision plays one of the most important roles and people’s lives are literally dependent on it. Hereby, any researches related to medicine are necessary to comply with the highest standards. The problem today is that any results of researches can be shared online and used as a reference without being properly verified and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this challenge and decided to create an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is based on Altmetric scores that are used as a quality measure. That helps both readers and authors to quality-check publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with corresponding scores above 100 as well as r

Далее...

hospitals in us

января 21, 2021

When people discuss contemporary medicine, accuracy plays one of the most crucial roles and people’s lives are literally dependent on it. Hence, any researches related to medicine are required to comply with the top standards. The problem today is that any conclusions of researches can be shared online and used as a reference without being adequately verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and attempted to come up with an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The main principle of this journal is based on Altmetric scores that are used as a quality indicator. That allows both readers and authors to verify publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website demonstrates a full publications list with respective scores higher t

Далее...

Downregulation of T-Box 15 Gene Found as Prognostic Biomarker of HCC

января 21, 2021

A genome-wide analysis of DNA methylation concluded that the TBX15 gene is hypermethylated and downregulated in tumors of patients with hepatocellular carcinoma. Listen to an audio version of this article Hepatocellular carcinoma is considered rare, though, it is also the most common primary tumor of the liver. Fortunately, most patients do not suffer from symptoms in the earlier stages of this disease. Unfortunately, patients diagnosed with late-stage hepatocellular carcinoma often present with symptoms caused by an underlying liver disease. “Hepatocellular carcinoma (HCC) is the sixth most prevalent human cancer and third-highest cause of cancer-related deaths worldwide, and its incidence is significantly increasing [1, 2].” Due to the high rate of post-treatment HCC relapse and metastasis, researchers based out of Japan—from the Institute of Biomedical Sciences at Tokushima University, Kumamoto University, and Kyushu University Beppu Hospital—conducted a full-genome analysis of

Далее...